CNS & Neurological Disorders - Drug Targets
Title:Potassium Channels and CNS Diseases
Volume: 17 Issue: 4
Author(s): Yian Huang, Jie Tao and Rong Zhao
Affiliation:
Export Options
About this article
Cite this article as:
Huang Yian , Tao Jie and Zhao Rong , Potassium Channels and CNS Diseases, CNS & Neurological Disorders - Drug Targets 2018; 17 (4) . https://dx.doi.org/10.2174/187152731704180706105155
DOI https://dx.doi.org/10.2174/187152731704180706105155 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
47
5
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Neurosteroids and Sporadic Alzheimers Disease
Current Alzheimer Research Synaptic Plasticity, Metaplasticity and Depression
Current Neuropharmacology Erythropoietin: A Neuroprotective Agent in Cerebral Hypoxia, Neurodegeneration, and Epilepsy
Current Pharmaceutical Design Synaptic Potentiation and Sleep Need: Clues from Molecular and Electrophysiological Studies
Current Topics in Medicinal Chemistry Antiepileptic Drug-Induced Hypersensitivity Syndrome Reactions
Current Drug Safety Clozapine Safety, 40 Years Later
Current Drug Safety Inflammasome and Atherogenesis
Current Pharmaceutical Design Clinical Pharmacokinetics of Retigabine/Ezogabine
Current Clinical Pharmacology Structure-Retention Relationship Study of HPLC Data of Antiepileptic Hydantoin Analogues
Current Computer-Aided Drug Design Antiepileptic Drugs During Pregnancy: Pharmacokinetics and Transplacental Transfer
Current Pharmaceutical Biotechnology Raf Inhibitors as Therapeutic Agents Against Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Recent Patents on Biomedical Devices and Nanomaterials for Hyperthermal Therapy of Cancer
Recent Patents on Nanomedicine The Gastrin-Releasing Peptide Receptor as a Therapeutic Target in Central Nervous System Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Protein Synthesis and Assembly in Mitochondrial Disorders
Current Topics in Medicinal Chemistry Design, Synthesis and Evaluation of the Antidepressant and Anticonvulsant Activities of Triazole-Containing Benzo[d]oxazoles
CNS & Neurological Disorders - Drug Targets Possible Physiopathological Roles of the Transglutaminase Activity in the Etiopathogenesis of Human Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Action Mechanisms of Chinese Herbal Compound at the Molecular Level
Letters in Drug Design & Discovery Blood Pressure Reduction in the Primary and Secondary Prevention of Stroke
Current Vascular Pharmacology Fluorescent Probes for Cellular Assays
Combinatorial Chemistry & High Throughput Screening Structural MRI Biomarkers of Mild Cognitive Impairment from Young Elders to Centenarians
Current Alzheimer Research